Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

Author： Cavero I. Mestre M. Guillon J-M. Crumb W.

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.5, 2000-07, pp. : 947-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes: An Overview

By Ponti F.D.

Drug Safety, Vol. 25, Iss. 4, 2002-01 ,pp. : 263-286

Adis International

Access to resources Recommend Favorite

Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs: A Prospective, Observational Study in a Large Urban Academic Medical Center in the US

By Tisdale James E. Wroblewski Heather A.

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 459-470

Adis International

Access to resources Recommend Favorite

Antimalarial drugs: QT prolongation and cardiac arrhythmias

By Traebert Martin Dumotier Berengere

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 421-431

Informa Healthcare

Access to resources Recommend Favorite

Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics

By Nielsen Jimmi

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 473-490

Adis International

Access to resources Recommend Favorite

Drugs, QT Interval Prolongation and ICH E14: The Need to Get it Right

By Rashmi R. Shah

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite